On June 20, 2025, Director Zhang Miao of the First Branch of Anhui Provincial Drug Administration and his delegation visited Hefei Leecan Pharmaceutical for on-site research, providing assistance and guidance on the construction and development of Hefei Leecan Pharmaceutical, as well as the existing difficulties and challenges. The founder, chairman, and relevant personnel of Leecan Pharmaceutical accompanied the research.
At the research meeting, the founder and chairman of Leecan Pharmaceutical warmly welcomed and sincerely thanked the delegation from the First Branch of Anhui Provincial Drug Administration. Starting from his long-term experience in drug review, GCP verification and other related industries, he talked about his entrepreneurial journey, introduced the entrepreneurial background and mission of Leecan Pharmaceutical, and presented the book "Guidelines for the Management of Drug Clinical Trial Institutions" edited by himself to the research team on site. He said that whether it is continuous entrepreneurship or editing and publishing multiple monographs, they all want to contribute their modest efforts to improving the overall level of drug research and development and production in China. Subsequently, the quality manager reported in detail to the research team on the construction and development of Hefei Leecan Pharmaceutical, as well as the implementation of main responsibilities.
Director Zhang Miao introduced the establishment history, organizational structure, and scope of functions of the First Branch of Anhui Provincial Drug Administration. She highly recognized Leecan Pharmaceutical's entrepreneurial intention of "serving the country with technology and giving back to society" and highly praised Leecan Pharmaceutical's "Three Year Action Plan for High Quality Development (2024-2026)". She pointed out that this coincides with the theme of promoting high-quality development by the First Branch of Anhui Province, and encouraged Leecan Pharmaceutical to continue to focus on high-quality development, build a top high-end complex formulation research and industrialization base in China, and bravely move forward to achieve the noble mission of "technology enhances the quality of life".
Since settling in Hefei, Hefei Leecan Pharmaceutical Co., Ltd. has received strong attention and support from various levels of departments such as Anhui Province and Hefei City, and has achieved phased and gratifying results, which will usher in even better development prospects. Leecan Pharmaceutical will remain confident and live up to expectations, using high-quality drugs with independent technology and brands to benefit Chinese patients and make more contributions to the high-quality development of China's medical and health industry!